Table 1. Infliximab Biosimilar Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Infliximab Biosimilar Market Restraints

Table 3. Infliximab Biosimilar Market Trends

Table 4. Infliximab Biosimilar Industry Policy

Table 5. Global Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million

Table 6. Global Infliximab Biosimilar Revenue Market Share by Company, 2019-2023

Table 7. Global Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023

Table 9. Global Infliximab Biosimilar Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Infliximab Biosimilar Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Infliximab Biosimilar Mergers & Acquisitions, Expansion Plans

Table 12. Global Infliximab Biosimilar Manufacturers Product Type

Table 13. China Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million

Table 14. China Infliximab Biosimilar Revenue Market Share by Company, 2019-2023

Table 15. China Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Infliximab Biosimilar Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Infliximab Biosimilar Import & Export Trends

Table 19. Main Sources of China Infliximab Biosimilar Import

Table 20. Export Destination of China Infliximab Biosimilar

Table 21. Global Headquarters and Manufacturing Base of Infliximab Biosimilar Manufacturers

Table 22. Global Major Manufacturers, Infliximab Biosimilar Capacity Expansion and Future Plans

Table 23. Global Infliximab Biosimilar Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Infliximab Biosimilar Production by Region, 2019-2023, (K Units)

Table 25. Global Infliximab Biosimilar Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Infliximab Biosimilar Upstream (Raw Materials)

Table 27. Global Infliximab Biosimilar Typical Customers

Table 28. Infliximab Biosimilar Typical Distributors

Table 29. By Type, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Infliximab Biosimilar Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Infliximab Biosimilar Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Table 37. By Country, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Table 39. Napp Pharmaceuticals Group Company Information, Head Office, Market Area and Industry Position

Table 40. Napp Pharmaceuticals Group Infliximab Biosimilar Models, Specifications and Application

Table 41. Napp Pharmaceuticals Group Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. Napp Pharmaceuticals Group Company Profile and Main Business

Table 43. Napp Pharmaceuticals Group Recent Developments

Table 44. Janssen Biotech Company Information, Head Office, Market Area and Industry Position

Table 45. Janssen Biotech Infliximab Biosimilar Models, Specifications and Application

Table 46. Janssen Biotech Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Janssen Biotech Company Profile and Main Business

Table 48. Janssen Biotech Recent Developments

Table 49. Alvogen Company Information, Head Office, Market Area and Industry Position

Table 50. Alvogen Infliximab Biosimilar Models, Specifications and Application

Table 51. Alvogen Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Alvogen Company Profile and Main Business

Table 53. Alvogen Recent Developments

Table 54. Merck Company Information, Head Office, Market Area and Industry Position

Table 55. Merck Infliximab Biosimilar Models, Specifications and Application

Table 56. Merck Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Merck Company Profile and Main Business

Table 58. Merck Recent Developments

Table 59. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 60. Celltrion Infliximab Biosimilar Models, Specifications and Application

Table 61. Celltrion Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Celltrion Company Profile and Main Business

Table 63. Celltrion Recent Developments

Table 64. Pfizer(Ac Hospira) Company Information, Head Office, Market Area and Industry Position

Table 65. Pfizer(Ac Hospira) Infliximab Biosimilar Models, Specifications and Application

Table 66. Pfizer(Ac Hospira) Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Pfizer(Ac Hospira) Company Profile and Main Business

Table 68. Pfizer(Ac Hospira) Recent Developments

Table 69. Nippon Kayaku Company Information, Head Office, Market Area and Industry Position

Table 70. Nippon Kayaku Infliximab Biosimilar Models, Specifications and Application

Table 71. Nippon Kayaku Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. Nippon Kayaku Company Profile and Main Business

Table 73. Nippon Kayaku Recent Developments

List of Figure

Figure 1. Infliximab Biosimilar Picture

Figure 2. By Revenue, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Infliximab Biosimilar Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Infliximab Biosimilar Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Infliximab Biosimilar Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Infliximab Biosimilar Share of Global Market, 2019-2030

Figure 10. Global Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Infliximab Biosimilar Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Infliximab Biosimilar Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Infliximab Biosimilar Domestic VS Export, 2023

Figure 16. Global Infliximab Biosimilar Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Infliximab Biosimilar Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Infliximab Biosimilar Production Market Share & Forecast by Region, 2019-2030

Figure 19. Infliximab Biosimilar Industry Chain

Figure 20. Infliximab Biosimilar Procurement Model

Figure 21. Infliximab Biosimilar Sales Model

Figure 22. Infliximab Biosimilar Sales Channels, Direct Sales and Distribution

Figure 23. CT-P13/infliximab-dyyb

Figure 24. Remsima

Figure 25. Inflectra

Figure 26. By Type, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 28. By Type, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)

Figure 31. Crohn's Disease

Figure 32. Rheumatoid Arthritis

Figure 33. Ulcerative Colitis

Figure 34. Ankylosing Spondylitis

Figure 35. Plaque Psoriasis

Figure 36. Others

Figure 37. By Application, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Figure 38. By Application, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 39. By Application, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 40. By Application, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 41. By Application, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)

Figure 42. By Region, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 43. By Region, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 44. North America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, North America Infliximab Biosimilar Revenue Market Share, 2023

Figure 46. Europe Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, Europe Infliximab Biosimilar Revenue Market Share, 2023

Figure 48. Asia Pacific Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country/Region, Asia Pacific Infliximab Biosimilar Revenue Market Share, 2023

Figure 50. South America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. By Country, South America Infliximab Biosimilar Revenue Market Share, 2023

Figure 52. Middle East & Africa Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 53. U.S. Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, U.S. Infliximab Biosimilar Market Share, 2023

Figure 55. By Type, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 57. Europe Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, Europe Infliximab Biosimilar Market Share, 2023

Figure 59. By Type, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 61. China Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, China Infliximab Biosimilar Market Share, 2023

Figure 63. By Type, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 65. Japan Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, Japan Infliximab Biosimilar Market Share, 2023

Figure 67. By Type, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 69. South Korea Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, South Korea Infliximab Biosimilar Market Share, 2023

Figure 71. By Type, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 73. Southeast Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, Southeast Asia Infliximab Biosimilar Market Share, 2023

Figure 75. By Type, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 77. India Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, India Infliximab Biosimilar Market Share, 2023

Figure 79. By Type, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 81. Middle East & Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 82. By Company, Middle East & Asia Infliximab Biosimilar Market Share, 2023

Figure 83. By Type, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 84. By Application, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 85. Research Methodology

Figure 86. Breakdown of Primary Interviews

Figure 87. Bottom-up Approaches

Figure 88. Top-down Approaches